UKAD 2016 Gabriel Evans vs UKAD - Appeal

Related case:
UKAD 2015 UKAD vs Gabriel Evans
December 18, 2015

On 18 December 2015 the United Kingdom Anti-Doping (UKAD) imposed a 3 year and 6 month period of ineligiblity on the Athlete Gabriel Evans for the use and possession of the prohibited substance Erythropoietin (EPO).

Hereafter in May 2016 the Athlete appealed the UKAD decision of 18 December 2015 with the National Anti-Doping Panel Arbitral Tribunal.
The Athlete requested the Panel for a reduced sanction and asserted that the violation was not intending to improve his performance in competition, he was experimenting, and was in any case taking it only during training. In relation to his degree of fault the Athlete mentioned the absence of any formal anti-doping training, his age, inexperience and immaturity. The Athlete also argued that the sanction effects his full participation in sporting activities at the university.

The Panel finds that notwithstanding the Athlete’s age at the time and relative inexperience, he was an intelligent and well-educated young man who committed a very serious ant-doping violation in circumstances in which he must have known that what he was doing was wrong at every imaginable level. Far from thinking that he has been dealt with harshly, the view of the Panel is that he has been dealt with leniently.

Therefore on 5 July 2016 the National Anti-Doping Panel Arbitral Tribunal decides to dismiss the Athlete’s appeal and to uphold the UKAD decision of 18 December 2015.

Original document

Parameters

Legal Source
National Decisions
Date
5 July 2016
Arbitrator
Crystal, Terry
Norris, William
Sever, Peter
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Possession
Use / attempted use
Legal Terms
No intention to enhance performance
Period of ineligibility
Prompt / Timely Admission
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Erythropoietin (EPO)
Document type
Pdf file
Date generated
2 September 2016
Date of last modification
2 November 2016
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin